Drug Shortage Report for TARO-BOSENTAN
| Report ID | 173502 |
| Drug Identification Number | 02483149 |
| Brand name | TARO-BOSENTAN |
| Common or Proper name | BOSENTAN |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BOSENTAN |
| Strength(s) | 125MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 125 |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-01 |
| Estimated end date | 2023-06-30 |
| Actual end date | 2023-06-30 |
| Shortage status | Resolved |
| Updated date | 2023-07-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v34 | 2023-07-18 | French | Compare |
| v33 | 2023-07-18 | English | Compare |
| v32 | 2023-06-09 | French | Compare |
| v31 | 2023-06-09 | English | Compare |
| v30 | 2023-05-08 | French | Compare |
| v29 | 2023-05-08 | English | Compare |
| v28 | 2023-04-28 | French | Compare |
| v27 | 2023-04-28 | English | Compare |
| v26 | 2023-04-10 | French | Compare |
| v25 | 2023-04-10 | English | Compare |
| v24 | 2023-03-24 | French | Compare |
| v23 | 2023-03-24 | English | Compare |
| v22 | 2023-03-10 | French | Compare |
| v21 | 2023-03-10 | English | Compare |
| v20 | 2023-02-22 | French | Compare |
| v19 | 2023-02-22 | English | Compare |
| v18 | 2023-02-10 | French | Compare |
| v17 | 2023-02-10 | English | Compare |
| v16 | 2023-02-01 | French | Compare |
| v15 | 2023-02-01 | English | Compare |